- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative mechanisms of miR-34a regulation in cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 10, Pages e3100
Publisher
Springer Nature
Online
2017-10-12
DOI
10.1038/cddis.2017.495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Identification of targets of tumor suppressor microRNA-34a using a reporter library system
- (2017) Yoshiaki Ito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
- (2016) Aymone Gurtner et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
- (2016) Peixin Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex
- (2016) F Garibaldi et al. ONCOGENE
- DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development
- (2016) Luqing Zhao et al. Scientific Reports
- microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
- (2015) Pengfei Qiao et al. BMC CANCER
- Combinatorial Action of MicroRNAslet-7and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
- (2015) Carlos Stahlhut et al. CELL CYCLE
- Micro(mi) RNA-34a targets protein phosphatase (PP)1γ to regulate DNA damage tolerance
- (2015) Yuko Takeda et al. CELL CYCLE
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues
- (2015) Liguang Wang et al. GENE
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database
- (2015) Chih-Hung Chou et al. NUCLEIC ACIDS RESEARCH
- Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells
- (2015) Chun-Yu Cho et al. RNA
- miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway
- (2015) Xinsen Xu et al. Oncotarget
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- MicroRNA Processing and Human Cancer
- (2015) Masahisa Ohtsuka et al. Journal of Clinical Medicine
- Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
- (2015) Yukiharu Hiyoshi et al. PLoS One
- miR-34 and p53: New Insights into a Complex Functional Relationship
- (2015) Francisco Navarro et al. PLoS One
- miR-34: from bench to bedside
- (2015) Massimiliano Agostini et al. Oncotarget
- MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
- (2014) Jian-Ya Zhou et al. CANCER LETTERS
- Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
- (2014) Masaki Mori et al. CELL
- Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
- (2014) Ramiro París et al. CELL CYCLE
- miR-34a is essential for p19Arf-driven cell cycle arrest
- (2014) Nida Iqbal et al. CELL CYCLE
- Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
- (2014) Feng Gao et al. CURRENT CANCER DRUG TARGETS
- A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
- (2014) N. Okada et al. GENES & DEVELOPMENT
- Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation
- (2014) W. Fan et al. JOURNAL OF CELL SCIENCE
- IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
- (2014) Matjaz Rokavec et al. JOURNAL OF CLINICAL INVESTIGATION
- SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes
- (2014) Katharine J Herbert et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110
- (2014) Rui Song et al. NATURE
- Two miRNA clusters, miR-34b/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis
- (2014) J. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53/miR-34 axis in development and disease
- (2014) M. Rokavec et al. Journal of Molecular Cell Biology
- OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation
- (2014) W L Ng et al. Cell Death & Disease
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- miR-34 Cooperates with p53 in Suppression of Prostate Cancer by Joint Regulation of Stem Cell Compartment
- (2014) Chieh-Yang Cheng et al. Cell Reports
- Mir-34: A New Weapon Against Cancer?
- (2014) Gabriella Misso et al. Molecular Therapy-Nucleic Acids
- Thyroid hormone inhibits TGFβ1 induced renal tubular epithelial to mesenchymal transition by increasing miR34a expression
- (2013) Xiaozhao Lu et al. CELLULAR SIGNALLING
- SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition
- (2013) Stefanie Hahn et al. EMBO JOURNAL
- TP53-independent Function of miR-34a via HDAC1 and p21CIP1/WAF1
- (2013) Jane Zhao et al. MOLECULAR THERAPY
- MicroRNA-34a regulates cardiac ageing and function
- (2013) Reinier A. Boon et al. NATURE
- DNA methylation: roles in mammalian development
- (2013) Zachary D. Smith et al. NATURE REVIEWS GENETICS
- MicroRNA-34a Enhances T Cell Activation by Targeting Diacylglycerol Kinase ζ
- (2013) Jinwook Shin et al. PLoS One
- Synthetic pre-microRNAs reveal dual-strand activity of miR-34a on TNF-
- (2013) B. Guennewig et al. RNA
- Epigenetic Regulation of miR-34a Expression in Alcoholic Liver Injury
- (2012) Fanyin Meng et al. AMERICAN JOURNAL OF PATHOLOGY
- Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells
- (2012) Juan Li et al. BMC MOLECULAR BIOLOGY
- microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status
- (2012) Xi Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
- (2012) Pengyuan Yang et al. CANCER CELL
- Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia
- (2012) C. Baer et al. CANCER RESEARCH
- miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma
- (2012) A. L. Kasinski et al. CANCER RESEARCH
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
- (2012) Helge Siemens et al. CELL CYCLE
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and -Catenin Predicts Distant Metastasis of Colon Cancer
- (2012) H. Siemens et al. CLINICAL CANCER RESEARCH
- MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages
- (2012) Pei Jiang et al. EXPERIMENTAL CELL RESEARCH
- BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex
- (2012) Shinji Kawai et al. JOURNAL OF CELL BIOLOGY
- ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
- (2012) Young-Ho Ahn et al. JOURNAL OF CLINICAL INVESTIGATION
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells
- (2012) Rui Du et al. PLoS One
- MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame
- (2012) Pooja Mandke et al. PLoS One
- Intact p53-Dependent Responses in miR-34–Deficient Mice
- (2012) Carla P. Concepcion et al. PLoS Genetics
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
- (2011) V. J. Craig et al. BLOOD
- Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide
- (2011) Ewy Mathé et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
- (2011) Ruth L. Vinall et al. INTERNATIONAL JOURNAL OF CANCER
- Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma
- (2011) Wong INTERNATIONAL JOURNAL OF ONCOLOGY
- Suppression of Latent Transforming Growth Factor (TGF)-β1 Restores Growth Inhibitory TGF-β Signaling through microRNAs
- (2011) Afzal M. Dogar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. MOLECULAR BIOLOGY OF THE CELL
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription
- (2011) Emily C. Knouf et al. NUCLEIC ACIDS RESEARCH
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
- (2011) Hanna Peurala et al. PLoS One
- Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets
- (2011) M. Agostini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
- (2011) Markus Vogt et al. VIRCHOWS ARCHIV
- MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251
- (2010) Shihai Luan et al. ARCHIVES OF MEDICAL RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
- (2010) D. C. Corney et al. CLINICAL CANCER RESEARCH
- MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1
- (2010) Dinesh S. Rao et al. IMMUNITY
- Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells
- (2010) Dario Antonini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Smad Proteins Bind a Conserved RNA Sequence to Promote MicroRNA Maturation by Drosha
- (2010) Brandi N. Davis et al. MOLECULAR CELL
- TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
- (2010) Xiaohua Su et al. NATURE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- p63 and p73, the Ancestors of p53
- (2010) V. Dotsch et al. Cold Spring Harbor Perspectives in Biology
- Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples
- (2009) Chunlei He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
- (2009) N R Christoffersen et al. CELL DEATH AND DIFFERENTIATION
- Reduced levels of miR-34a in neuroblastoma are not caused by mutations in theTP53binding site
- (2009) Galina Feinberg-Gorenshtein et al. GENES CHROMOSOMES & CANCER
- miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
- (2009) M Mraz et al. LEUKEMIA
- Modulation of microRNA processing by p53
- (2009) Hiroshi I. Suzuki et al. NATURE
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- miR-34a as part of the resistance network in chronic lymphocytic leukemia
- (2008) T. Zenz et al. BLOOD
- The Quest for the 1p36 Tumor Suppressor
- (2008) A. Bagchi et al. CANCER RESEARCH
- Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
- (2008) Marjorie Robbins et al. HUMAN GENE THERAPY
- 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
- (2008) M K Dijkstra et al. LEUKEMIA
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started